TrueFG’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

TrueFG’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Buy	+863	New	+$186K	0.05%	70

Other funds holding FBT

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Ocean Park Asset Management Santa Monica, California $2.08B AUM 5.32% 1-Year Est. Return

Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

Trust Company of Oklahoma Tulsa, Oklahoma $389M AUM 34.72% 1-Year Est. Return

Stablepoint Partners Braintree, Massachusetts $723M AUM 29.31% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return

TrueFG's FBT Position: Q2 2026 in Review

TrueFG opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 863 shares worth $214K. The stake represents 0.05% of the portfolio and ranks #70 among its holdings.

51 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

TrueFG held 863 shares of First Trust NYSE Arca Biotechnology Index Fund worth $214K as of Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new TrueFG position in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of TrueFG's portfolio in Q2 2026, its #70 holding.
51 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on TrueFG's 13F filing for Q2 2026, filed 16 Jul 2026.